The role of iNKT cells in the immunopathology of systemic lupus erythematosus

L Gabriel, Bernard J Morley, NJ Rogers, Y Shoenfeld (Editor), ME Gershwin (Editor)

Research output: Contribution to conferencePaper


An increasing body of evidence suggests that CD1d-restricted invariant natural killer T (iNKT) cells play an important immunoregulatory role in a variety of autoimmune diseases in both humans and mouse models. Their role in systemic lupus erythematosus (SLE), however, is not fully determined, as SLE mouse models have yielded conflicting results demonstrating both a protective function and a pathogenic role. The reduced frequency of iNKT cells in peripheral blood of lupus patients supports the idea of a protective role for these cells in the immunopathology of SLE. Therapeutic approaches using glycolipids provide a promising tool to correct numerical iNKT cell deficiencies and to modulate their function. This review highlights the potential role of iNKT cells in lupus immunopathology and summarizes recent studies concerning iNKT cells in SLE patients, lupus-prone murine models and glycolipid therapy.
Original languageEnglish
Number of pages7
Publication statusPublished - 2008
Event6th International Congress on Autoimmunity - Porto, Portugal
Duration: 10 Sept 200814 Sept 2008


Conference6th International Congress on Autoimmunity


Dive into the research topics of 'The role of iNKT cells in the immunopathology of systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this